Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
BioAtla Inc (NASDAQ: BCAB) closed the day trading at $0.86 down -1.39% from the previous closing price of $0.87. In other words, the price has decreased by -$1.39 from its previous closing price. On the day, 3.97 million shares were traded. BCAB stock price reached its highest trading level at $1.04 during the session, while it also had its lowest trading level at $0.7001.
On September 15, 2022, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $17.JMP Securities initiated its Mkt Outperform rating on September 15, 2022, with a $17 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCAB now has a Market Capitalization of 50390700 and an Enterprise Value of 48251700.
Stock Price History:
The Beta on a monthly basis for BCAB is 0.90, which has changed by -0.44649684 over the last 52 weeks, in comparison to a change of 0.09654534 over the same period for the S&P500. Over the past 52 weeks, BCAB has reached a high of $1.90, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is 13.42%, while the 200-Day Moving Average is calculated to be 74.67%.
Shares Statistics:
Over the past 3-months, BCAB traded about 1.38M shares per day on average, while over the past 10 days, BCAB traded about 2904120 shares per day. A total of 58.79M shares are outstanding, with a floating share count of 45.63M. Insiders hold about 22.39% of the company’s shares, while institutions hold 15.75% stake in the company. Shares short for BCAB as of 1761868800 were 4521208 with a Short Ratio of 3.27, compared to 1759190400 on 4282858. Therefore, it implies a Short% of Shares Outstanding of 4521208 and a Short% of Float of 8.63.
Earnings Estimates
A detailed examination of BioAtla Inc (BCAB) is currently in progress, with 2.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.2 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$1.05 and -$1.08 for the fiscal current year, implying an average EPS of -$1.07. EPS for the following year is -$0.79, with 2.0 analysts recommending between -$0.65 and -$0.92.
